Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Acurx Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ACXP
Nasdaq
8731
https://www.acurxpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Acurx Pharmaceuticals Inc
Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV
- Mar 21st, 2024 11:01 am
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
- Mar 19th, 2024 1:32 pm
Q4 2023 Acurx Pharmaceuticals Inc Earnings Call
- Mar 19th, 2024 2:01 am
We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully
- Mar 18th, 2024 1:34 pm
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
- Mar 18th, 2024 11:01 am
Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update
- Mar 4th, 2024 12:01 pm
Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development
- Feb 27th, 2024 12:01 pm
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series
- Feb 23rd, 2024 2:30 pm
New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT
- Feb 16th, 2024 2:30 pm
New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT
- Feb 2nd, 2024 2:30 pm
New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT
- Feb 1st, 2024 2:33 pm
Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
- Jan 29th, 2024 12:00 pm
New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT
- Jan 26th, 2024 3:55 pm
Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024
- Jan 23rd, 2024 12:01 pm
New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT
- Jan 19th, 2024 2:30 pm
Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?
- Jan 17th, 2024 6:26 pm
Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
- Jan 17th, 2024 12:01 pm
New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT
- Jan 5th, 2024 2:30 pm
Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 1:00 pm
Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure
- Dec 11th, 2023 12:01 pm
Scroll